BR0016864A - Sistema de fornecimento de quelante de ferro, e, métodos de preparação de um sistema de fornecimento de quelante de ferro e de tratamento de sobrecarga de ferro em um mamìfero em necessidade de tratamento - Google Patents

Sistema de fornecimento de quelante de ferro, e, métodos de preparação de um sistema de fornecimento de quelante de ferro e de tratamento de sobrecarga de ferro em um mamìfero em necessidade de tratamento

Info

Publication number
BR0016864A
BR0016864A BR0016864-5A BR0016864A BR0016864A BR 0016864 A BR0016864 A BR 0016864A BR 0016864 A BR0016864 A BR 0016864A BR 0016864 A BR0016864 A BR 0016864A
Authority
BR
Brazil
Prior art keywords
iron
treatment
supply system
iron chelator
methods
Prior art date
Application number
BR0016864-5A
Other languages
English (en)
Inventor
Judith K Gwathmey
Original Assignee
Judith K Gwathmey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Judith K Gwathmey filed Critical Judith K Gwathmey
Publication of BR0016864A publication Critical patent/BR0016864A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feeding And Controlling Fuel (AREA)

Abstract

"SISTEMA DE FORNECIMENTO DE QUELANTE DE FERRO, E, MéTODOS DE PREPARAçãO DE UM SISTEMA DE FORNECIMENTO DE QUELANTE DE FERRO E DE TRATAMENTO DE SOBRECARGA DE FERRO EM UM MAMìFERO EM NECESSIDADE DE TRATAMENTO". é descrito um sistema de fornecimento de quelante de ferro. O sistema compreende quelante de ferro e um veículo de lipídeo, por exemplo, um lipossoma. Métodos para preparar e administrar o sistema de fornecimento de quelante de ferro são também providos.
BR0016864-5A 1999-12-30 2000-12-29 Sistema de fornecimento de quelante de ferro, e, métodos de preparação de um sistema de fornecimento de quelante de ferro e de tratamento de sobrecarga de ferro em um mamìfero em necessidade de tratamento BR0016864A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17392499P 1999-12-30 1999-12-30
PCT/US2000/035644 WO2001049266A2 (en) 1999-12-30 2000-12-29 Iron chelator delivery system

Publications (1)

Publication Number Publication Date
BR0016864A true BR0016864A (pt) 2002-09-24

Family

ID=22634086

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016864-5A BR0016864A (pt) 1999-12-30 2000-12-29 Sistema de fornecimento de quelante de ferro, e, métodos de preparação de um sistema de fornecimento de quelante de ferro e de tratamento de sobrecarga de ferro em um mamìfero em necessidade de tratamento

Country Status (11)

Country Link
US (1) US6960560B2 (pt)
EP (1) EP1246606A2 (pt)
AP (1) AP2002002546A0 (pt)
AU (1) AU2609601A (pt)
BR (1) BR0016864A (pt)
CA (2) CA2733819A1 (pt)
CR (1) CR6683A (pt)
MX (1) MXPA02006121A (pt)
OA (1) OA12210A (pt)
WO (1) WO2001049266A2 (pt)
ZA (1) ZA200206024B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8029795B2 (en) * 1999-12-30 2011-10-04 Gwathmey, Inc. Targeted iron chelator delivery system
US20030109548A1 (en) * 2001-11-09 2003-06-12 Royt Paulette W. Compositions and methods of treating iron excess
US7160855B2 (en) * 2002-03-14 2007-01-09 Children's Hospital & Research Center At Oakland Enhancement of iron chelation therapy
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
WO2012006101A2 (en) 2010-06-28 2012-01-12 The General Hospital Corporation Blood substitutes and uses thereof
EP2793860A1 (en) 2011-12-22 2014-10-29 Nuvo Research GmbH Liposomal chlorite or chlorate compositions
US20130330274A1 (en) * 2012-05-22 2013-12-12 University of Virginia Patent Foundation d/b/a University of Virginia Licensing & Ventures Group Compositions and methods for detecting and treating cancer
JP2015524411A (ja) 2012-07-18 2015-08-24 オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． エポキシケトン系プロテアソーム阻害剤のリポソーム組成物
US20150246027A1 (en) 2012-11-12 2015-09-03 Cipla Limited Fixed dose pharmaceutical composition comprising deferasirox and deferiprone
KR102554628B1 (ko) 2013-02-01 2023-07-12 존원 파마, 인코포레이티드 리포좀 내로 난수용성 약물의 원격 부하
CA2906794A1 (en) * 2013-03-14 2014-09-25 Zoneone Pharma, Inc. Pharmaceutical formulations of chelating agents as a metal removal treatment system
EP3538546B1 (en) 2016-11-14 2025-01-08 Novartis AG Compositions, methods, and therapeutic uses related to fusogenic protein minion
DK3684344T3 (da) 2017-10-25 2025-08-04 Chiesi Farm Spa Deferipron-tabletter med forsinket frigivelse og fremgangsmåder til anvendelse deraf
EP4153192B8 (en) 2020-05-19 2024-09-04 Institut Curie Antagonist of cd44/hyaluronic acid pathway for use in a method for the treatment of cytokine release syndrome
CN113952317A (zh) * 2021-11-10 2022-01-21 河北师范大学 一种血小板-dfo脂质体纳米颗粒、制备方法和应用
US12016851B2 (en) 2022-04-11 2024-06-25 Chiesi Farmaceutici S.P.A. Modified release pharmaceutical formulations comprising deferiprone
US12016850B2 (en) 2022-04-11 2024-06-25 Chiesi Farmaceutici S.P.A. Modified release pharmaceutical formulations comprising deferiprone
CN115594841B (zh) * 2022-10-09 2024-06-04 四川大学 没食子酸-聚赖氨酸螯合剂及其制备方法与应用
CN115607683B (zh) * 2022-10-24 2023-10-27 浙江大学 一种壳聚糖-去铁胺复合纳米悬浊液及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201010A (en) * 1981-06-19 1986-02-21 Ciba Geigy Ag The treatment of inflammation diseases using desferrioxamine
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5143713A (en) 1990-05-30 1992-09-01 Board Of Regents, The University Of Texas System 99m Tc labeled liposomes
US5534241A (en) * 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
US6057115A (en) * 1995-06-16 2000-05-02 Ludwig Institute For Cancer Research Process for producing GM2 specific antibodies

Also Published As

Publication number Publication date
MXPA02006121A (es) 2004-08-23
CR6683A (es) 2003-12-04
CA2394717A1 (en) 2001-07-12
WO2001049266A2 (en) 2001-07-12
WO2001049266A3 (en) 2002-03-21
US6960560B2 (en) 2005-11-01
OA12210A (en) 2006-05-09
ZA200206024B (en) 2003-02-25
AP2002002546A0 (en) 2002-06-30
CA2733819A1 (en) 2001-07-12
US20010033860A1 (en) 2001-10-25
AU2609601A (en) 2001-07-16
CA2394717C (en) 2011-05-17
EP1246606A2 (en) 2002-10-09

Similar Documents

Publication Publication Date Title
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
PL319833A1 (en) Compounds and composition for carrying active media
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
DE69417232D1 (de) Intravaginales wirkstoffabgabesystem
IL140710A0 (en) Pulmonary delivery of active agents
AP2002002546A0 (en) Iron chelator delivery system.
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
AU7315301A (en) Compounds and compositions for delivering active agents
YU37301A (sh) Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
IL149336A0 (en) Phenyl amine carboxylic acid compounds and compositions for delivering active agents
IL144597A0 (en) Hydrogel particle formulations
DK0774959T3 (da) Liposomalt indgivelsessystem for biologisk aktive midler
BR9908273A (pt) Formulações
ATE423547T1 (de) N-acyl-phosphatidylethanolamin-vermittelte wirkstoffdarreichung in liposomenform
DE60024414T2 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
AP1901A (en) Pharmaceutical composition for modified release insulin sensitiser.
PT1135193E (pt) Agentes para o tratamento de tumores a base de lipossomas e compreendendo tamoxifeno
SE9402880D0 (sv) New peptide derivatives
GB9816899D0 (en) Therapeutic agents
BRPI0515756A (pt) sistema de fornecimento de quelador de ferro direcionado
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ES2181407T3 (es) Glucocorticoides para tratar la glomerulonefritis.
GEP20053444B (en) Immunogenic Liposome Compositions
AP1692A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]